Trademarkia Logo

Canada

C$
ZYLA
SEARCHED

on 7 May 2024

Last Applicant/ Owned by

Zyla Life Sciences US, LLC

100 S. Saunders Rd., Suite 300Lake Forest, IL 60045

US

Serial Number

1992932 filed on 29th Oct 2019

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

ZYLA

Trademark usage description

pharmaceutical preparations for the treatment, prevention and management of central nervous system [cns] diseases; pharmaceutical preparations for the Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment, prevention and management of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of pain and pain associated with inflammation; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory pelvic diseases; all the foregoing excluding for use in maintaining oral health and consistent blood glucose levels, and excluding sweeteners, sweetening agents and sugar substitutes


Classification kind code

12

Class [035]
Advertising, marketing, promotional and business


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Computer and scientific


Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details


Serial Number

1992932

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 67
on 27th Sept 2024
Agent Name Changed
Submitted for opposition 22
on 7th May 2024
Search Recorded
Submitted for opposition 20
on 7th May 2024
Examiner's First Report
Submitted for opposition 135
on 11th Apr 2023
Amendment to Application
Submitted for opposition 287
on 3rd Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 15th Nov 2019
Formalized
Submitted for opposition 1
on 30th Oct 2019
Created
Submitted for opposition 30
on 29th Oct 2019
Filed